Please provide your email address to receive an email when new articles are posted on . In a randomized double blind, placebo-controlled trial with older men assigned either AndroGel 1% (transdermal ...

PARSIPPANY, N.J., Oct. 21, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that the U.S. Food and Drug Administration (FDA) approved its Androderm® (testosterone ...

Men with low testosterone should go for intramuscular rather than transdermal replacement formulations, according to a new clinical practice guideline from the American College of Physicians (ACP). In ...

The FDA has approved Androderm (testosterone transdermal system; Watson) in 2mg and 4mg formulations. The smaller-sized and lower-dose patch reflects a 20% reduction in the active ingredient from the ...

Injectable testosterone esters and transdermal testosterone gels have generally been assumed to be equally safe and effective forms of testosterone-replacement therapy for male hypogonadism. Now, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SAN FRANCISCO - A retrospective case series of 10 ...

Intramuscular injection of testerosterone replacement therapy confers greater health benefits and lower cardiovascular risks than transdermal administration by skin patch or gel, a new study concludes ...

At birth, 1-2 million follicles are present in the ovaries, and the number declines to 400,000-500,000 by menarche. The rate of follicle loss is genetically programmed at the individual level. As the ...

Testosterone has been used for substitution therapy in testicular and hypothalamopituitary diseases for almost six decades, with injectable testosterone esters and implanted testosterone pellets being ...

Many older men take testosterone supplements in the hope of recapturing some of their youthful vigor. According to a new study, doing so won't help functional fitness in already-active older men. The ...